Ayuda
Ir al contenido

Dialnet


Essential and Orphan Drugs in Panama: Perception of Competition and Implications of Pricing Policy

  • Autores: Víctor H. Herrera Ballesteros, Ilais Moreno, Eric I. Conte, Cecilio N. Hall, Beatriz Gómez
  • Localización: Revista de economía del Rosario, ISSN 0123-5362, Vol. 23, Nº. 2, 2020
  • Idioma: inglés
  • Títulos paralelos:
    • Medicamentos essenciais e órfãos no Panamá: percepção da concorrência e implicações da política de preços
    • Medicamentos esenciales y huérfanos en Panamá: percepción de la competencia e implicaciones de la política de precios
  • Enlaces
  • Resumen
    • We measured the perception of competition in the market for essential and orphan drugs. The inflation rate for original products was 0.002 annually, whereas that for generic drugs was 0.005. The province of Panama, containing 46.5% of private pharmacies, has the lowest index in the perception of competition; 18% of the respondents to the out-of-pocket expenditure survey did not have drugs available, and 55% could not afford them. The Gini coefficients were 0.40 (2014) and 0.76 (2017). The increase in prices, the relative independence of retailers to establish prices, and low access to social/private insurance increase the out-of-pocket expenses.


Fundación Dialnet

Dialnet Plus

  • Más información sobre Dialnet Plus

Opciones de compartir

Opciones de entorno